Cardiovascular Risk Factor _targets and Cardiovascular Disease Event Risk in Diabetes: A Pooling Project of the Atherosclerosis Risk in Communities Study, Multi-Ethnic Study of Atherosclerosis, and Jackson Heart Study
- PMID: 27208374
- PMCID: PMC4839178
- DOI: 10.2337/dc15-2439
Cardiovascular Risk Factor _targets and Cardiovascular Disease Event Risk in Diabetes: A Pooling Project of the Atherosclerosis Risk in Communities Study, Multi-Ethnic Study of Atherosclerosis, and Jackson Heart Study
Abstract
Objective: Controlling cardiovascular disease (CVD) risk factors in diabetes mellitus (DM) reduces the number of CVD events, but the effects of multifactorial risk factor control are not well quantified. We examined whether being at _targets for blood pressure (BP), LDL cholesterol (LDL-C), and glycated hemoglobin (HbA1c) together are associated with lower risks for CVD events in U.S. adults with DM.
Research design and methods: We studied 2,018 adults, 28-86 years of age with DM but without known CVD, from the Atherosclerosis Risk in Communities (ARIC) study, Multi-Ethnic Study of Atherosclerosis (MESA), and Jackson Heart Study (JHS). Cox regression examined coronary heart disease (CHD) and CVD events over a mean 11-year follow-up in those individuals at BP, LDL-C, and HbA1c _target levels, and by the number of controlled risk factors.
Results: Of 2,018 DM subjects (43% male, 55% African American), 41.8%, 32.1%, and 41.9% were at _target levels for BP, LDL-C, and HbA1c, respectively; 41.1%, 26.5%, and 7.2% were at _target levels for any one, two, or all three factors, respectively. Being at BP, LDL-C, or HbA1c _target levels related to 17%, 33%, and 37% lower CVD risks and 17%, 41%, and 36% lower CHD risks, respectively (P < 0.05 to P < 0.0001, except for BP in CHD risk); those subjects with one, two, or all three risk factors at _target levels (vs. none) had incrementally lower adjusted risks of CVD events of 36%, 52%, and 62%, respectively, and incrementally lower adjusted risks of CHD events of 41%, 56%, and 60%, respectively (P < 0.001 to P < 0.0001). Propensity score adjustment showed similar findings.
Conclusions: Optimal levels of BP, LDL-C, and HbA1c occurring together in individuals with DM are uncommon, but are associated with substantially lower risk of CHD and CVD.
© 2016 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered.
Figures
Similar articles
-
Effect of Multifactorial Treatment _targets and Relative Importance of Hemoglobin A1c, Blood Pressure, and Low-Density Lipoprotein-Cholesterol on Cardiovascular Diseases in Chinese Primary Care Patients With Type 2 Diabetes Mellitus: A Population-Based Retrospective Cohort Study.J Am Heart Assoc. 2017 Aug 17;6(8):e006400. doi: 10.1161/JAHA.117.006400. J Am Heart Assoc. 2017. PMID: 28862945 Free PMC article.
-
Discordance of Low-Density Lipoprotein and High-Density Lipoprotein Cholesterol Particle Versus Cholesterol Concentration for the Prediction of Cardiovascular Disease in Patients With Metabolic Syndrome and Diabetes Mellitus (from the Multi-Ethnic Study of Atherosclerosis [MESA]).Am J Cardiol. 2016 Jun 15;117(12):1921-7. doi: 10.1016/j.amjcard.2016.03.040. Epub 2016 Apr 6. Am J Cardiol. 2016. PMID: 27156827 Free PMC article.
-
Combined association of lipids and blood pressure in relation to incident cardiovascular disease in the elderly: the cardiovascular health study.Am J Hypertens. 2010 Feb;23(2):161-7. doi: 10.1038/ajh.2009.216. Epub 2009 Nov 19. Am J Hypertens. 2010. PMID: 19927131 Free PMC article.
-
Effects of glucose-lowering on outcome incidence in diabetes mellitus and the modulating role of blood pressure and other clinical variables: overview, meta-analysis of randomized trials.J Hypertens. 2019 Oct;37(10):1939-1949. doi: 10.1097/HJH.0000000000002152. J Hypertens. 2019. PMID: 31157748 Review.
-
[Evidences from J-EDIT for diabetes mellitus in the elderly].Nihon Rinsho. 2013 Nov;71(11):1923-31. Nihon Rinsho. 2013. PMID: 24397160 Review. Japanese.
Cited by
-
We Know More Than We Can Tell About Diabetes and Vascular Disease: The 2016 Edwin Bierman Award Lecture.Diabetes. 2017 Jul;66(7):1735-1741. doi: 10.2337/db17-0093. Diabetes. 2017. PMID: 28637825 Free PMC article.
-
Polypills in the Management of Cardiovascular Risk-A Perspective.J Clin Med. 2024 Sep 16;13(18):5487. doi: 10.3390/jcm13185487. J Clin Med. 2024. PMID: 39336974 Free PMC article.
-
Risk factor control and cardiovascular events in patients with type 2 diabetes mellitus.PLoS One. 2024 Feb 29;19(2):e0299035. doi: 10.1371/journal.pone.0299035. eCollection 2024. PLoS One. 2024. PMID: 38422102 Free PMC article.
-
Metabolic reprogramming of the myeloid lineage by Schistosoma mansoni infection persists independently of antigen exposure.PLoS Pathog. 2021 Jan 8;17(1):e1009198. doi: 10.1371/journal.ppat.1009198. eCollection 2021 Jan. PLoS Pathog. 2021. PMID: 33417618 Free PMC article.
-
Five-year LDL-cholesterol trend and its predictors among type 2 diabetes patients in an upper-middle-income country: a retrospective open cohort study.PeerJ. 2022 Oct 26;10:e13816. doi: 10.7717/peerj.13816. eCollection 2022. PeerJ. 2022. PMID: 36317122 Free PMC article.
References
-
- American Diabetes Association Cardiovascular disease and risk management. Sec. 8. In Standards of Medical Care in Diabetes—2016. Diabetes Care 2016;39(Suppl. 1):S60–S71 - PubMed
-
- Fox CS, Golden SH, Anderson C, et al. .; American Heart Association Diabetes Committee of the Council on Lifestyle and Cardiometabolic Health, Council on Clinical Cardiology, Council on Cardiovascular and Stroke Nursing, Council on Cardiovascular Surgery and Anesthesia, Council on Quality of Care and Outcomes Research, and the American Diabetes Association . Update on prevention of cardiovascular disease in adults with type 2 diabetes mellitus in light of recent evidence: a scientific statement from the American Heart Association and the American Diabetes Association. Circulation 2015;132:691–718 - PMC - PubMed
-
- American Diabetes Association Standards of medical care for patients with diabetes mellitus. Diabetes Care 2000;23(Suppl. 1):S32–S42 - PubMed
-
- UK Prospective Diabetes Study (UKPDS) Group Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837–853 - PubMed
MeSH terms
Substances
Grants and funding
- HHSN268201100012C/HL/NHLBI NIH HHS/United States
- HHSN268201100009I/HL/NHLBI NIH HHS/United States
- N01HC95160/HL/NHLBI NIH HHS/United States
- HHSN268201100010C/HL/NHLBI NIH HHS/United States
- UL1 RR025005/RR/NCRR NIH HHS/United States
- N01HC95163/HL/NHLBI NIH HHS/United States
- HHSN268201100008C/HL/NHLBI NIH HHS/United States
- HHSN268201100005G/HL/NHLBI NIH HHS/United States
- R01 HL117285/HL/NHLBI NIH HHS/United States
- HHSN268201100008I/HL/NHLBI NIH HHS/United States
- HHSN268201100007C/HL/NHLBI NIH HHS/United States
- N01HC95169/HL/NHLBI NIH HHS/United States
- HHSN268201100011I/HL/NHLBI NIH HHS/United States
- HHSN268201100011C/HL/NHLBI NIH HHS/United States
- HHSN268201300048C/HL/NHLBI NIH HHS/United States
- N01HC95164/HL/NHLBI NIH HHS/United States
- N01HC95162/HL/NHLBI NIH HHS/United States
- N01HC95168/HL/NHLBI NIH HHS/United States
- HHSN268201100006C/HL/NHLBI NIH HHS/United States
- HHSN268201300049C/HL/NHLBI NIH HHS/United States
- HHSN268201100005I/HL/NHLBI NIH HHS/United States
- K24 DK106414/DK/NIDDK NIH HHS/United States
- N01HC95165/HL/NHLBI NIH HHS/United States
- N01HC95159/HL/NHLBI NIH HHS/United States
- R01 HL128801/HL/NHLBI NIH HHS/United States
- N01HC95161/HL/NHLBI NIH HHS/United States
- HHSN268201300047C/HL/NHLBI NIH HHS/United States
- HHSN268201300050C/HL/NHLBI NIH HHS/United States
- N01HC95167/HL/NHLBI NIH HHS/United States
- HHSN268201100009C/HL/NHLBI NIH HHS/United States
- HHSN268201100005C/HL/NHLBI NIH HHS/United States
- HHSN268201100007I/HL/NHLBI NIH HHS/United States
- UL1 TR000040/TR/NCATS NIH HHS/United States
- HHSN268201300046C/HL/NHLBI NIH HHS/United States
- N01HC95166/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical